Anastasia Suraev

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Neuropathic Pain

Cross Sectional

Placebo Controlled

Top Venues

Nature and science of sleep

Drug testing and analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Anastasia Suraev, Danielle McCartney, Richard Kevin, Rebecca Gordon, Ronald R Grunstein, Camilla M Hoyos, Iain S McGregor
Detection of Δ 9 -tetrahydrocannabinol (THC) in oral fluid using two point-of-collection testing devices following oral administration of a THC and cannabidiol containing oil. Drug testing and analysis (2024)
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey. Nature and science of sleep 15 (2023)
Isobel Lavender, Danielle McCartney, Nathaniel Marshall, Anastasia Suraev, Chris Irwin, Angela L D'Rozario, Christopher J Gordon, Bandana Saini, Ronald R Grunstein, Brendon Yee, Iain McGregor, Camilla M Hoyos
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. BMJ open 13 (8) (2023)
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey. Nature and science of sleep 15 (2023)
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey. Nature and science of sleep 15 (2023)
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, Thomas R Arkell, Nicholas Lintzeris, Iain S McGregor
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey. Nature and science of sleep 15 (2023)
Anastasia Suraev, Ronald R Grunstein, Nathaniel S Marshall, Angela L D'Rozario, Christopher J Gordon, Delwyn J Bartlett, Keith Wong, Brendon J Yee, Ryan Vandrey, Chris Irwin, Jonathon C Arnold, Iain S McGregor, Camilla M Hoyos
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ open 10 (5) (2020)